SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (993)4/29/2001 11:04:27 PM
From: Spekulatius  Read Replies (1) of 3158
 
Peter, Roche (RHHBY) has about a total of 8.6M Shares, which are valued at about 8000 Euro each, so the total market cap is a tad less than 70 B Euro of 63B$.
Last time I looked, Roche had about 10B US$ in cash.
Their 59% ownership in DNA is worth 15.8 B US$, so the core business itself is only valued at 37 B$. Quite affordable by todays standards. Of course the family still has control but the recent developments (Share split 1:100) and news from management let me believe that this may change (it certainly has to change if they pursue mergers). A few 100 million $ in fines to IGEN would be no more than a drop in the bucket, IMHO.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News